Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Caenepeel, S; Brown, SP; Belmontes, B; Moody, G; Keegan, KS; Chui, D; Whittington, DA; Huang, X; Poppe, L; Cheng, AC; Cardozom, M; Houze, J; Li, YX; Lucas, B; Paras, NA; Wang, XH; Taygerly, JP; Vimolratana, M; Zancanella, M; Zhu, LS; Cajulis, E; Osgood, T; Sun, J; Damon, L; Egan, RK; Greninger, P; McClanaghan, JD; Gong, JN; Moujalled, D; Pomilio, G; Beltran, P; Benes, CH; Roberts, AW; Huang, DC; Wei, A; Canon, J; Coxon, A; Hughes, PE
(2018), Cancer Discov., 1582-1597
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
Buchbinder, D; Kelly, DL; Duarte, RF; Auletta, JJ; Bhatt, N; Byrne, M; DeFilipp, Z; Gabriel, M; Mahindra, A; Norkin, M; Schoemans, H; Shah, AJ; Ahmed, I; Atsuta, Y; Basak, GW; Beattie, S; Bhella, S; Bredeson, C; Bunin, N; Dalal, J; Daly, A; Gajewski, J; Gale, RP; Galvin, J; Hamadani, M; Hayashi, RJ; Adekola, K; Law, J; Lee, CJ; Liesveld, J; Malone, AK; Nagler, A; Naik, S; Nishihori, T; Parsons, SK; Scherwath, A; Schofield, HL; Soiffer, R; Szer, J; Twist, I; Warwick, AB; Wirk, BM; Yi, J; Battiwalla, M; Flowers, MDE; Savani, B; Shaw, BE
(2018), Bone Marrow Transplant., 535-555
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
Biegstraaten, M; Cox, TM; Belmatoug, N; Berger, MG; Collin-Histed, T; Dahl, SV; Di Rocco, M; Fraga, C; Giona, F; Giraldo, P; Hasanhodzic, M; Hughes, DA; Iversen, PO; Kiewiet, AI; Lukina, E; Machaczka, M; Marinakis, T; Mengel, E; Pastores, GM; Plockinger, U; Rosenbaum, H; Serratrice, C; Symeonidis, A; Szer, J; Timmerman, J; Tylki-Szymanska, A; Hubshman, MW; Zafeiriou, DI; Zimran, A; Hollak, CEM
(2018), Blood Cells Mol. Dis., 203-208
Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model
Bellgard, MI; Napier, KR; Bittles, AH; Szer, J; Fletcher, S; Zeps, N; Hunter, AA; Goldblatt, J
(2018), Blood Cells Mol. Dis., 232-238
Absence of renal phenotype in hereditary haemorrhagic telangiectasia
Healy, L; Nicholls, K; Gibson, R; Stella, D; Bogwitz, M; Taylor, J; Walsh, M; Donaldson, L; Winship, I
(2018), Intern. Med. J., 1255-1257
DOI: 10.1111/imj.14059
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial
Walker, JG; Macrae, F; Winship, I; Oberoi, J; Saya, S; Milton, S; Bickerstaffe, A; Dowty, JG; Lourenco, RD; Clark, M; Galloway, L; Fishman, G; Walter, FM; Flander, L; Chondros, P; Ouakrim, DA; Pirotta, M; Trevena, L; Jenkins, MA; Emery, JD
(2018), Trials
Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same
Huq, AJ; Walsh, M; Rajagopalan, B; Finlay, M; Trainer, AH; Bonnet, F; Sevenet, N; Winship, IM
(2018), Fam. Cancer, 601-606
Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios
Dillon, M; Flander, L; Buchanan, DD; Macrae, FA; Emery, JD; Winship, IM; Boussioutas, A; Giles, GG; Hopper, JL; Jenkins, MA; Ouakrim, DA
(2018), PLos Med.
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1
Buchanan, DD; Stewart, JR; Clendenning, M; Rosty, C; Mahmood, K; Pope, BJ; Jenkins, MA; Hopper, JL; Southey, MC; Macrae, FA; Winship, IM; Win, AK
(2018), Genet. Med., 890-895
DOI: 10.1038/gim.2017.185
Spotlight on the utility of the Oncotype DX (R) breast cancer assay
Siow, ZR; De Boer, RH; Lindeman, GJ; Mann, GB
(2018), Int. J. Womens Health, 89-100
DOI: 10.2147/IJWH.S124520
No live vaccines for people being treated with leflunomide Reply
Wong, PKK; Hanrahan, P; Johnson, DF
(2018), Intern. Med. J., 1280-1281
DOI: 10.1111/imj.14053
Cancer Risks for PMS2-Associated Lynch Syndrome
ten Broeke, SW; van der Klift, HM; Tops, CMJ; Aretz, S; Bernstein, I; Buchanan, DD; de la Chapelle, A; Capella, G; Clendenning, M; Engel, C; Gallinger, S; Gomez Garcia, E; Figueiredo, JC; Haile, R; Hampel, HL; Hopper, JL; Hoogerbrugge, N; Doeberitz, MV; Le Marchand, L; Letteboer, TGW; Jenkins, MA; Lindblom, A; Lindor, NM; Mensenkamp, AR; Moller, P; Newcomb, PA; van Os, TAM; Pearlman, R; Pineda, M; Rahner, N; Redeker, EJW; Olderode-Berends, MJW; Rosty, C; Schackert, HK; Scott, R; Senter, L; Spruijt, L; Steinke-Lange, V; Suerink, M; Thibodeau, S; Vos, YJ; Wagner, A; Winship, I; Hes, FJ; Vasen, HFA; Wijnen, JT; Nielsen, M; Win, AK
(2018), J. Clin. Oncol., 2961-+
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Rebbeck, TR; Friebel, TM; Friedman, E; Hamann, U; Huo, DZ; Kwong, A; Olah, E; Olopade, OI; Solano, AR; Teo, SH; Thomassen, M; Weitzel, JN; Chan, TL; Fergus, J; Goldgar, DE; Kruse, TA; Edenir, I; Park, SK; Torres, D; van Rensburg, EJ; McGuffog, L; Parsons, MT; Leslie, G; Aalfs, CM; Abugattas, J; Adlard, J; Agata, S; Aittomaki, K; Andrews, L; Andrulis, IL; Arason, A; Arnold, N; Arun, BK; Asseryanis, E; Auerbach, L; Azzollini, J; Balmana, J; Barile, M; Barkardottir, RB; Barrowdale, D; Benitez, J; Berger, A; Berger, R; Blanco, AM; Blazer, KR; Blok, MJ; Bonadona, V; Bonanni, B; Bradbury, AR; Brewer, C; Buecher, B; Buys, SS; Caldes, T; Caliebe, A; Caligo, MA; Campbell, I; Caputo, SM; Chiquette, J; Chung, WK; Claes, KBM; Collee, JM; Cook, J; Davidson, R; de la Hoya, M; De Leeneer, K; de Pauw, A; Delnatte, C; Diez, O; Ding, YC; Ditsch, N; Domchek, S; Dorfling, CM; Velazquez, C; Dworniczak, B; Eason, J; Easton, DF; Eeles, R; Ehrencrona, H; Ejlertsen, B; Engel, C; Engert, S; Evans, DG; Faivre, L; Feliubadalo, L; Ferrer, SF; Foretova, L; Fowler, J; Frost, D; Galvao, HCR; Ganz, PA; Garber, J; Gauthier-Villars, M; Gehrig, A; Gerdes, AM; Gesta, P; Giannini, G; Giraud, S; Glendon, G; Godwin, AK; Greene, MH; Gronwald, J; Gutierrez-Barrera, A; Hahnen, E; Hauke, J; Henderson, A; Hentschel, J; Hogervorst, FBL; Honisch, E; Imyanitov, EN; Isaacs, C; Izatt, L; Izquierdo, A; Jakubowska, A; James, P; Janavicius, R; Jensen, UB; John, EM; Vijai, J; Kaczmarek, K; Karlan, BY; Kast, K; Kim, SW; Konstantopoulou, I; Korach, J; Laitman, Y; Lasa, A; Lasset, C; Lazaro, C; Lee, A; Lee, MH; Lester, J; Lesueur, F; Liljegren, A; Lindor, NM; Longy, M; Loud, JT; Lu, KH; Lubinski, J; Machackova, E; Manoukian, S; Mari, V; Martinez-Bouzas, C; Matrai, Z; Mebirouk, N; Meijers-Heijboer, HEJ; Meindl, A; Mensenkamp, AR; Mickys, U; Miller, A; Montagna, M; Moysich, KB; Mulligan, AM; Musinsky, J; Neuhausen, SL; Nevanlinna, H; Ngeow, J; Nguyen, HP; Niederacher, D; Nielsen, HR; Nielsen, FC; Nussbaum, RL; Offit, K; Ofverholm, A; Ong, KR; Osorio, A; Papi, L; Papp, J; Pasini, B; Pedersen, IS; Peixoto, A; Peruga, N; Peterlongo, P; Pohl, E; Pradhan, N; Prajzendanc, K; Prieur, F; Pujol, P; Radice, P; Ramus, SJ; Rantala, J; Rashid, MU; Rhiem, K; Robson, M; Rodriguez, GC; Rogers, MT; Rudaitis, V; Schmidt, AY; Schmutzler, RK; Senter, L; Shah, PD; Sharma, P; Side, LE; Simard, J; Singer, CF; Skytte, AB; Slavin, TP; Snape, K; Sobol, H; Southey, M; Steele, L; Steinemann, D; Sukiennicki, G; Sutter, C; Szabo, CI; Tan, YY; Teixeira, MR; Terry, MB; Teule, A; Thomas, A; Thull, DL; Tischkowitz, M; Tognazzo, S; Toland, AE; Topka, S; Trainer, AH; Tung, N; van Asperen, CJ; van der Hout, AH; van der Kolk, LE; van der Luijt, RB; Van Heetvelde, M; Varesco, L; Varon-Mateeva, R; Vega, A; Villarreal-Garza, C; von Wachenfeldt, A; Walker, L; Wang-Gohrke, S; Wappenschmidt, B; Weber, BHF; Yannoukakos, D; Yoon, SY; Zanzottera, C; Zidan, J; Zorn, KK; Selkirk, CGH; Hulick, PJ; Chenevix-Trench, G; Spurdle, AB; Antoniou, AC; Nathanson, KL
(2018), Hum. Mutat., 593-620
DOI: 10.1002/humu.23406
Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments
Petelin, L; Liew, D; Mitchell, G; James, PA; Trainer, AH
(2018), Value Health, 891-893
Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia
Petelin, L; James, PA; Trainer, AH
(2018), Intern. Med. J., 1269-+
DOI: 10.1111/imj.14058
A theory-informed systematic review of clinicians' genetic testing practices
Paul, JL; Leslie, H; Trainer, AH; Gaff, C
(2018), Eur. J. Hum. Genet., 1401-1416
Identification of nine new susceptibility loci for endometrial cancer
O'Mara, TA; Glubb, DM; Amant, F; Annibali, D; Ashton, K; Attia, J; Auer, PL; Beckmann, MW; Black, A; Bolla, MK; Brauch, H; Brenner, H; Brinton, L; Buchanan, DD; Burwinkel, B; Chang-Claude, J; Chanock, SJ; Chen, C; Chen, MM; Cheng, THT; Clarke, CL; Clendenning, M; Cook, LS; Couch, FJ; Cox, A; Crous-Bous, M; Czene, K; Day, F; Dennis, J; Depreeuw, J; Doherty, JA; Dork, T; Dowdy, SC; Durst, M; Ekici, AB; Fasching, PA; Fridley, BL; Friedenreich, CM; Fritschi, L; Fung, J; Garcia-Closas, M; Gaudet, MM; Giles, GG; Goode, EL; Gorman, M; Haiman, CA; Hall, P; Hankison, SE; Healey, CS; Hein, A; Hillemanns, P; Hodgson, S; Hoivik, EA; Holliday, EG; Hopper, JL; Hunter, DJ; Jones, A; Krakstad, C; Kristensen, VN; Lambrechts, D; Le Marchand, L; Liang, XL; Lindblom, A; Lissowska, J; Long, JR; Lu, LG; Magliocco, AM; Martin, L; McEvoy, M; Meindl, A; Michailidou, K; Milne, RL; Mints, M; Montgomery, GW; Nassir, R; Olsson, H; Orlow, I; Otton, G; Palles, C; Perry, JRB; Peto, J; Pooler, L; Prescott, J; Proietto, T; Rebbeck, TR; Risch, HA; Rogers, PAW; Rubner, M; Runnebaum, I; Sacerdote, C; Sarto, GE; Schumacher, F; Scott, RJ; Setiawan, VW; Shah, M; Sheng, X; Shu, XO; Southey, MC; Swerdlow, AJ; Tham, E; Trovik, J; Turman, C; Tyrer, JP; Vachon, C; Vanden Berg, D; Vanderstichele, A; Wang, ZM; Webb, PM; Wentzensen, N; Werner, HMJ; Winham, SJ; Wolk, A; Xia, L; Xiang, YB; Yang, HP; Yu, H; Zheng, W; Pharoah, PDP; Dunning, AM; Kraft, P; De Vivo, I; Tomlinson, I; Easton, DF; Spurdle, AB; Thompson, DJ
(2018), Nat. Commun.
Is RNASEL:p.Glu265*a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
Nguyen-Dumont, T; Teo, ZL; Hammet, F; Roberge, A; Mahmoodi, M; Tsimiklis, H; Park, DJ; Pope, BJ; Lonie, A; Kapuscinski, MK; Mahmood, K; Goldgar, DE; Giles, GG; Winship, I; Hopper, JL; Southey, MC
(2018), BMC Cancer
Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer
Neumeyer, S; Banbury, BL; Arndt, V; Berndt, SI; Bezieau, S; Bien, SA; Buchanan, DD; Butterbach, K; Caan, BJ; Campbell, PT; Casey, G; Chan, AT; Chanock, SJ; Dai, JY; Gallinger, S; Giovannucci, EL; Giles, GG; Grady, WM; Hampe, J; Hoffmeister, M; Hopper, JL; Hsu, L; Jenkins, MA; Joshi, A; Larsson, SC; Le Marchand, L; Lindblom, A; Moreno, V; Lemire, M; Li, L; Lin, Y; Offit, K; Newcomb, PA; Pharaoh, PD; Potter, JD; Qi, LH; Rennert, G; Schafmayer, C; Schoen, RE; Slattery, ML; Song, MY; Ulrich, CM; Win, AK; White, E; Wolk, A; Woods, MO; Wu, AH; Gruber, SB; Brenner, H; Peters, U; Chang-Claude, J
(2018), Br. J. Cancer, 1639-1647
Targeting DNA repair: the genome as a potential biomarker
Nesic, K; Wakefield, M; Kondrashova, O; Scott, CL; McNeish, IA
(2018), J. Pathol., 586-597
DOI: 10.1002/path.5025
Endometrial cancer risk and survival by tumor MMR status
Nagle, CM; O'Mara, TA; Tan, Y; Buchanan, DD; Obermair, A; Blomfield, P; Quinn, MA; Webb, PM; Spurdle, AB
(2018), J. Gynecol. Oncol.
Subacute Rehabilitation Does Have Benefits for Patients With Advanced Cancer
Morgan, DD; Marston, C; Garner, J; Currow, DC
(2018), J. Pain Symptom Manage., E1-E2
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
Mikropoulos, C; Selkirk, CGH; Saya, S; Bancroft, E; Vertosick, E; Dadaev, T; Brendler, C; Page, E; Dias, A; Evans, DG; Rothwell, J; Maehle, L; Axcrona, K; Richardson, K; Eccles, D; Jensen, T; Osther, PJ; van Asperen, CJ; Vasen, H; Kiemeney, LA; Ringelberg, J; Cybulski, C; Wokolorczyk, D; Hart, R; Glover, W; Lam, J; Taylor, L; Salinas, M; Feliubadalo, L; Oldenburg, R; Cremers, R; Verhaegh, G; van Zelst-Stams, WA; Oosterwijk, JC; Cook, J; Rosario, DJ; Buys, SS; Conner, T; Domchek, S; Powers, J; Ausems, MGEM; Teixeira, MR; Maia, S; Izatt, L; Schmutzler, R; Rhiem, K; Foulkes, WD; Boshari, T; Davidson, R; Ruijs, M; Helderman-van den Enden, ATJM; Andrews, L; Walker, L; Snape, K; Henderson, A; Jobson, I; Lindeman, GJ; Liljegren, A; Harris, M; Adank, MA; Kirk, J; Taylor, A; Susman, R; Chen-Shtoyerman, R; Pachter, N; Spigelman, A; Side, L; Zgajnar, J; Mora, J; Brewer, C; Gadea, N; Brady, AF; Gallagher, D; van Os, T; Donaldson, A; Stefansdottir, V; Barwell, J; James, PA; Murphy, D; Friedman, E; Nicolai, N; Greenhalgh, L; Obeid, E; Murthy, V; Copakova, L; McGrath, J; Teo, SH; Strom, S; Kast, K; Leongamornlert, DA; Chamberlain, A; Pope, J; Newlin, AC; Aaronson, N; Ardern-Jones, A; Bangma, C; Castro, E; Dearnaley, D; Eyfjord, J; Falconer, A; Foster, CS; Gronberg, H; Hamdy, FC; Johannsson, O; Khoo, V; Lubinski, J; Grindedal, EM; McKinley, J; Shackleton, K; Mitra, AV; Moynihan, C; Rennert, G; Suri, M; Tricker, K; Moss, S; Kote-Jarai, Z; Vickers, A; Lilja, H; Helfand, BT; Eeles, RA
(2018), Br. J. Cancer, 266-276
DOI: 10.1038/bjc.2017.429
Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids
Michalak, EM; Milevskiy, MJG; Joyce, RM; Dekkers, JF; Jamieson, PR; Pal, B; Dawson, CA; Hu, YF; Orkin, SH; Alexander, WS; Lindeman, GJ; Smyth, GK; Visvader, JE
(2018), PLoS. Biol.
Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers
Mascarenhas, L; Shanley, S; Mitchell, G; Spurdle, AB; Macrae, F; Pachter, N; Buchanan, DD; Ward, RL; Fox, S; Duxbury, E; Driessen, R; Boussioutas, A
(2018), Asia-Pac. J. Clin. Oncol., 417-425
DOI: 10.1111/ajco.13076
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
Li, N; Rowley, SM; Thompson, ER; McInerny, S; Devereux, L; Amarasinghe, KC; Zethoven, M; Lupat, R; Goode, D; Li, J; Trainer, AH; Gorringe, KL; James, PA; Campbell, IG
(2018), Breast Cancer Res.
Mutations in RECQL are not associated with breast cancer risk in an Australian population
Li, N; Rowley, SM; Goode, DL; Amarasinghe, KC; McInerny, S; Devereux, L; Wong-Brown, MW; Lupat, R; Lee, JEA; Hughes, S; Thompson, ER; Zethoven, M; Li, J; Trainer, AH; Gorringe, KL; Scott, RJ; James, PA; Campbell, IG
(2018), Nature Genet., 1346-1348
Molecular analysis of PALB2-associated breast cancers
Lee, JEA; Li, N; Rowley, SM; Cheasley, D; Zethoven, M; McInerny, S; Gorringe, KL; James, PA; Campbell, IG
(2018), J. Pathol., 53-60
DOI: 10.1002/path.5055
Ethics, health policy, and Zika: From emergency to global epidemic?
Jamrozik, E; Selgelid, MJ
(2018), J. Med. Ethics, 343-348
Maximizing the Clinical Benefit of DPYD Genotyping: Extending the Opportunity of Personalized Management to Family Members Through Cascade Testing
Higgs, EJ; Phillips, KA; Lo, LL; Winship, IM
(2018), JCO Precis. Oncol., 1-5
DOI: 10.1200/PO.18.00093